1.
|
Phase: Phase III, Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA183-002, NCT00389155
|
|
2.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: L0070 IN 302 P1, CA183004, NCT00315237
|
|
3.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BMS-CA183001, UPCC-07804, NCT00101608
|
|
4.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: I-05-009, NCT00251446
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: SCRI LUN 122, CA183017, NCT00284154
|
|
6.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: SCRI BRE 89, CA183014, NCT00284180
|
|
7.
|
Phase: Phase II Type: Treatment Status: Temporarily closed Age: 18 and over Sponsor: Other Protocol IDs: LCCC 0503, NCT00330031
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N0632, N0632, NCT00450515
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UNC-LCCC-0503, LCCC 0503, NCT00519831
|
|
10.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: SCRI GU 35, NCT00545766
|
|
11.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA183-008, NCT00362830
|
|
12.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA183-009, NCT00388557
|
|
13.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UNC-LCCC-0509, LCC 0506, NCT00320073
|